article thumbnail

COVID-19 Showcased Failed Global Cooperation

Bill of Health

By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over. Public health emergencies aren’t entirely preventable. Solidarity operates at two intersecting levels.

COVID-19 299
article thumbnail

The Case for Procurement Transparency

Bill of Health

By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines. Impact of the judgment: what have records disclosed shown?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Discovery Outsourcing Market Expected to Reach $7.5B by 2033

HIT Consultant

The research report on the drug discovery outsourcing market states that the pharmaceutical industry is expanding thoroughly with new extensions and high-end research programs. As COVID-19 pandemic garnered the pharmaceutical industry, new viruses and their penetration in developed nations are also increasing drug consumption.

article thumbnail

U.S. Hospitals Will Lose $323 Billion in 2020 – Before Accounting for Growing COVID Cases

Health Populi

health systems are projected to lose $323 billion in 2020 due to declining inpatient and outpatient volumes caused by the COVID-19 pandemic’s impact on the “normal” hospital business. Some hospitals in regions of these states are approaching full capacity in ICUs and COVID units.

Hospitals 124
article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

article thumbnail

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment

Bill of Health

By Nikhil Chaudhry and Reshma Ramachandran Earlier this month, the Department of Health and Human Services announced that it had successfully included a reasonable pricing provision in a $326M investment contract with Regeneron for development of a next generation monoclonal antibody therapy for COVID-19. pharmaceutical market.

COVID-19 205